Taxus Cardium Pharmaceuticals Group (CRXM) Q2 2013 Earnings

30SepConfirmed
Nov 12
Apr 13
Aug 13
Q2 2013
-0.4
-0.33
-0.27
-0.2

Details

Expected EPS
-0.2
Actual EPS
-0.243
Surprise EPS
-0.04
Surprise Percent
+21.5%

Description

Taxus Cardium Pharmaceuticals Group (CRXM) has reported earnings of -0.243 per share for Q2 2013.

0 Comments

Share your thoughts